Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias

STUDY OBJECTIVE: To estimate the incidence of 10 common cancers among patients treated with antimuscarinic medications for overactive bladder (AMOABs). DESIGN: Retrospective cohort study. DATA SOURCE: United Kingdom's Clinical Practice Research Datalink. PATIENTS: A total of 119,912 adults with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaye, James A., Margulis, Andrea V., Fortuny, Joan, McQuay, Lisa J., Plana, Estel, Bartsch, Jennifer L., Bui, Christine L., Perez‐Gutthann, Susana, Arana, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518180/
https://www.ncbi.nlm.nih.gov/pubmed/28370075
http://dx.doi.org/10.1002/phar.1932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518180/
https://www.ncbi.nlm.nih.gov/pubmed/28370075
http://dx.doi.org/10.1002/phar.1932

Ejemplares similares